Details of the Drug

General Information of Drug (ID: DMRGSKK)

Drug Name
Gadoteridol
Synonyms ProHance; SQ-32692; GD-HP-DO 3A; Gadolinium-HP-D03A
Indication
Disease Entry ICD 11 Status REF
Brain disease 8C70-8E61 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
V08CA04: Gadoteridol
V08CA: Paramagnetic contrast media
V08C: MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
V08: CONTRAST MEDIA
V: VARIOUS
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C17H29GdN4O7
Canonical SMILES
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
InChI
1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3
InChIKey
DPNNNPAKRZOSMO-UHFFFAOYSA-K
Cross-matching ID
PubChem CID
60714
CAS Number
120066-54-8
UNII
0199MV609F
DrugBank ID
DB00597
TTD ID
D0M1PL
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015